Literature DB >> 30672444

Hsa_circRNA_0059655 plays a role in salivary adenoid cystic carcinoma by functioning as a sponge of miR-338-3p.

Fei Zhao1, Chu-Wen Chen1, Wen-Wen Yang1, Li-Hua Xu1, Zhi-Hao Du1, Xi-Yuan Ge1, Sheng-Lin Li1.   

Abstract

Circular RNAs(circRNA) are recently demonstrated to have a close relationship with tumors.To investigate the role of circular RNA in the pathogenesis of salivary adenoid cystic carcinoma(SACC), ten SACC tissues and paired normal submandibular gland(SMG) tissues were collected as the tumor group and the control group. Total RNA was extracted and then measured using ceRNA microarray (including mRNA, lncRNA, and circRNA) and miRNA microarray. Gene Ontology(GO) analysis and Kyoto Encyclopedia of Gene and Genomes (KEGG) pathway analysis were performed in order to investigate the function of the differential expressing genes. The ceRNA regulatory network was constructed to find the core circRNAs. Then the role of circRNA on proliferation was examined in the SACC cell line SACC-83 using CCK-8,qRT-PCR and western blotting, and its roles on migration and invasion were examined using wound healing assay and transwell assay. The results of the microarrays showed that 3792 mRNAs, 7649 lncRNAs, 11553 circRNAs, and 132 miRNAs expressed differentially. The ceRNA regulatory network analysis showed that hsa_circ_0059655 and other 14circRNAs derived from PYGB target on several similar genes by miR-338-3p.Among the 15 circRNAs derived from PYGB, hsa_circ_0059655has the most relationships in the ceRNA network. Furthermore, after hsa_circ_0059655 was knocked down in SACC-83 cells, the expression of hsa-miR-338-3p was up-regulated while CCND1was down-regulated. The proliferation, migration, and invasion of SACC-83 cells also decreased after hsa_circ_0059655 knock-downed.Taken together, the circRNAs derived from PYGB may regulate the tumorigenesis and development of SACC through competing with miR-338-3p.

Entities:  

Keywords:  Salivary adenoid cystic carcinoma; ceRNA.; hsa_circRNA_0059655

Mesh:

Substances:

Year:  2018        PMID: 30672444

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  7 in total

Review 1.  Functional and Clinical Impact of CircRNAs in Oral Cancer.

Authors:  Ion Cristóbal; Cristina Caramés; Jaime Rubio; Marta Sanz-Alvarez; Melani Luque; Juan Madoz-Gúrpide; Federico Rojo; Jesús García-Foncillas
Journal:  Cancers (Basel)       Date:  2020-04-23       Impact factor: 6.639

2.  SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway.

Authors:  Xiaobai Liu; Shuyuan Shen; Lu Zhu; Rui Su; Jian Zheng; Xuelei Ruan; Lianqi Shao; Di Wang; Chunqing Yang; Yunhui Liu
Journal:  J Exp Clin Cancer Res       Date:  2020-06-29

3.  Circular RNA Circ_0025033 Promotes the Evolvement of Ovarian Cancer Through the Regulation of miR-330-5p/KLK4 Axis.

Authors:  Hailing Cheng; Ning Wang; Jun Tian; Yanyun Li; Lu Ren; Zhenyu Shi
Journal:  Cancer Manag Res       Date:  2020-04-23       Impact factor: 3.989

4.  H19- and hsa-miR-338-3p-mediated NRP1 expression is an independent predictor of poor prognosis in glioblastoma.

Authors:  Yong Liu; Yuelin Liu; Yong Gao; Lei Wang; Hengliang Shi; Chengmin Xuan
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

5.  Circular RNA-0001283 Suppresses Breast Cancer Proliferation and Invasion via MiR-187/HIPK3 Axis.

Authors:  Ying Hu; Feixiang Guo; Hongquan Zhu; Xiaobin Tan; Xiansen Zhu; Xiaofeng Liu; Wei Zhang; Qiong Yang; Yaling Jiang
Journal:  Med Sci Monit       Date:  2020-02-18

6.  Knockdown of circSMAD2 inhibits the tumorigenesis of gallbladder cancer through binding with eIF4A3.

Authors:  Yiyu Qin; Yongliang Zheng; Cheng Huang; Yuanyuan Li; Min Gu; Qin Wu
Journal:  BMC Cancer       Date:  2021-11-02       Impact factor: 4.430

7.  Circular RNA circ_0001162 promotes cell proliferation and invasion of glioma via the miR-936/ERBB4 axis.

Authors:  Dexiang Zhou; Xiaofeng Lin; Peng Wang; Yong Yang; Jiantao Zheng; Dong Zhou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.